Cluster-randomized trial of devices to prevent catheter-related bloodstream infection
Journal of the American Society of Nephrology Feb 28, 2018
Brunelli SM, et al. - Rate of catheter-related bloodstream infections (BSIs) was compared among patients undergoing hemodialysis in facilities using ClearGuard HD antimicrobial barrier caps vs Tego connectors plus Curos disinfecting caps. In this 13-month, prospective, cluster-randomized, open-label trial, it was demonstrated that ClearGuard HD antimicrobial barrier caps vs Tego connectors plus Curos caps significantly lowered the rate of catheter-related BSIs in patients undergoing hemodialysis using central venous catheters (CVCs).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries